Innate and acquired immunity to Herpes simplex virus type 1

Virology

Volumn 236, Issue 2, 1997, Pages 328-337

  Halford, William P ^a   Veress, Livia A ^a   Gebhardt, Bryan M ^a   Carr, Daniel J J ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; HERPES; HERPES SIMPLEX VIRUS 1; IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRIGEMINUS GANGLION; VIRUS REPLICATION;

ANIMALIA; HERPES; HUMAN HERPESVIRUS 1;

EID: 0030845850     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8738     Document Type: Article

References (45)

1. Bonneau R. H., Jennings S. J. Modulation of acute and latent herpes simplex virus infection in C57BL/6 mice by adoptive transfer of immune lymphocytes with cytolytic activity. J. Virol. 63:1989;1480-1484.
2. Brenner G. J., Cohen N., Moynihan J. A. Similar immune response to nonlethal infection with herpes simplex virus-1 in sensitive (BALB/c) and resistant (C57BL/6) strains of mice. Cell. Immunol. 157:1994;510-524.
3. Cantin E. M., Hinton D. R., Chen J., Openshaw H. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J. Virol. 69:1995;4898-4905.
4. Chen S.-H., Oakes J. E., Lausch R. N. Synergistic anti-HSV effect of tumor necrosis factor alpha and interferon gamma in human corneal fibroblasts is associated with interferon beta induction. Antiviral Res. 22:1993;15-29.
5. Cox D. R. Regression models and life tables. J. R. Stat. Soc. Ser. B. 34:1972;87.
6. Engler H., Zawatzky R., Goldbach A., Schroder C. H., Weyand C., Hammerling G. J., Kirchner H. Experimental infection of inbred mice with herpes simplex virus. II. Interferon production and activation of natural killer cells in the peritoneal exudate. J. Gen. Virol. 55:1981;25-30.
7. Erturk M., Hill T. J., Shimeld C., Jennings R. Acute and latent infection of mice immunized with HSV-1 ISCOM vaccine. Arch. Virol. 125:1992;87-101.
8. Feduchi E., Alonso M. A., Carrasco L. Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. J. Virol. 63:1989;1354-1359.
9. Green M. T., Courtney R. J., Dunkel E. C. Detection of an immediate early herpes simplex virus type 1 polypeptide in trigeminal ganglia from latently infected animals. Infect. Immun. 34:1981;987-992.
10. Halford W. P., Gebhardt B. M., Carr D. J. J. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J. Immunol. 157:1996;3542-3549.
11. Hay K. A., Gaydos A., Tenser R. B. The role of herpes simplex thymidine kinase expression in neurovirulence and latency in newborn vs. adult mice. J. Neuroimmunol. 61:1995;41-52.
12. Hendricks R. L., Weber P. C., Taylor J. L., Koumbis A., Tumpey T. M., Glorioso J. C. Endogenously produced interferon α protects mice from herpes simplex virus type 1 corneal disease. J. Gen. Virol. 72:1991;1601-1610.
13. Johnson H. M. Cellular recognition of immune interferon production. Antiviral Res. 1:1981;37.
14. Kanangat S., Thomas J., Gangappa S., Babu J. S., Rouse B. T. Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression. J. Immunol. 156:1996;1110-1116.
15. Kintner R. L., Brandt C. R. The effect of viral inoculum level and host age on disease incidence, disease severity, and mortality in a murine model of ocular HSV-1 infection. Curr. Eye Res. 14:1995;145-152.
16. Knoblich A., Gortz J., Harle-Grupp V., Falke D. Kinetics and genetics of herpes simplex virus-induced antibody formation in mice. Infect. Immun. 39:1983;15-23.
17. Kosz-Vnenchak M., Jacobson J., Coen D. M., Knipe D. M. Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons. J. Virol. 67:1993;5358-5393.
18. Kramer M., Coen D. M. Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 69:1995;1389-1399.
19. Lewandowski G., Hobbs M. V., Bloom F. E. Alteration of intracerebral cytokine production in mice infected with herpes simplex virus types 1 and 2. J. Neuroimmunol. 55:1994;23-34.
20. Lewandowski G. A., Lo D., Bloom F. E. Interference with major histocompatibility complex class II-restricted antigen presentation in the brain by herpes simplex virus type 1: A possible mechanism of evasion of the immune response. Proc. Natl. Acad. Sci. USA. 90:1993;2005-2009.
21. Linnavuori K., Hovi T. Restricted replication of herpes simplex virus in human monocyte cultures: Role of interferon. Virology. 130:1983;1-9.
22. Liu T., Tang Q., Hendricks R. L. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 70:1996;264-271.
23. Manickan E., Rouse B. T. Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse models. J. Virol. 69:1995;8178-8179.
24. McKendall R. R., Klassen T., Baringer J. R. Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread. Infect. Immun. 23:1979;305-311.
25. Mitchell B. M., Stevens J. G. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response. J. Immunol. 156:1996;246-255.
26. Mittnacht S., Straub P., Kirchner H., Jacobsen H. Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription. Virology. 164:1988;201-210.
27. Morrison L. A., Knipe D. M. Immunization with replication defective mutants of herpes simplex virus type 1: Sites of immune intervention in pathogenesis of challenge virus infection. J. Virol. 68:1994;689-696.
28. Munoz A., Carrasco L. Formation of non-infective herpesvirus particles in cultured cells treated with human interferon. J. Gen. Virol. 65:1984;1069-1078.
29. ++. J. Gen. Virol. 68:1987;825-833.
30. Nichol P. F., Chang J. Y., Johnson E. M. Jr., Olivo P. D. Herpes simplex virus gene expression in neurons: Viral DNA synthesis is a critical regulatory event in the branch point between the lytic and latent pathway. J. Virol. 70:1996;5476-5486.
31. Oakes J. E., Davis W. B., Taylor J. A., Weppner W. A. Lymphocyte reactivity contributes to protection conferred by specific antibody passively transferred to herpes simplex virus-infected mice. Infect. Immun. 29:1980;642-649.
32. Oakes J. E., Lausch R. N. Monoclonal antibodies suppress replication of herpes simplex virus type 1 in the trigeminal ganglion. J. Virol. 51:1984;656-661.
33. Pereira R. A., Tscharke D. C., Simmons A. Upregulation of class I major histocompatibility complex gene expression in primary sensory neurons, satellite cells, and schwann cells of mice in response to acute but not latent herpes simplex virus infection in vivo. J. Exp. Med. 18:1994;841-850.
34. Perng G.-C., Homayon G., Slanina S. M., Nesburn A. B., Wechsler S. L. High dose ocular infection with a herpes simplex virus type 1 ICP34.5 deletion mutant produces no corneal disease or neurovirulence yet results in wild type levels of spontaneous reactivation. J. Virol. 70:1996;2883-2893.
35. Rouse B. T., Larsen H. S., Wagner H. Frequency of cytotoxic T lymphocyte precursors to herpes simplex virus type 1 as determined by limiting dilution analysis. Infect. Immun. 39:1983;785-792.
36. Schroder C. H., Kumel G., Glorioso J., Kirchner H., Kaerner H. C. Neuropathogenicity of herpes simplex virus in mice: Protection against lethal encephalitis by co-infection with a non-encephaltitogenic strain. J. Gen. Virol. 64:1983;1973-1982.
37. Shimeld C., Hill T., Blyth B., Easty D. An improved model of recurrent herpetic disease in mice. Curr. Eye Res. 8:1989;1193-1205.
38. Shimeld C., Whiteland J. L., Nicholls S. M., Grinfeld E., Easty D. L., Gao H., Hill T. J. Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J. Neuroimmunol. 61:1995;7-16.
39. Simmons A., Tscharke D. C. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: Implications for the fate of virally infected neurons. J. Exp. Med. 175:1992;1337-1344.
40. Stevens J. G., Cook M. L. Latent herpes simplex virus in spinal ganglia of mice. Science. 173:1971;843-845.
41. Stevens J. G., Cook M. L. Maintenance of latent herpetic infection: An apparent role for anti-viral IgG. J. Immunol. 113:1974;1685-1693.
42. Straub P., Domke I., Kirchner H., Jacobsen H., Panet A. Synthesis of herpes simplex virus proteins and nucleic acids in interferon-treated macrophages. Virology. 150:1986;411-418.
43. Tamesis R. R., Messmer E. M., Rice B. A., Dutt J. E., Foster C. S. The role of natural killer cells in the development of herpes simplex virus type 1 induced stromal keratitis in mice. Eye. 8:1994;298-306.
44. Tumpey T. M., Chen S. H., Oakes J. E., Lausch R. N. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J. Virol. 70:1996;898-904.
45. Zawatsky R., Gresser I., DeMaeyer E., Kirchner H. The role of interferon in the resistance of C57BL/6 mice to various doses of herpes simplex virus type 1. J. Infect. Dis. 146:1982;405-410.